Michelle A. Hodges - 30 Jan 2026 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Role
Chief Legal Officer
Signature
/s/ Phillip S. Askim, attorney-in-fact for Michelle A. Hodges
Issuer symbol
QDEL
Transactions as of
30 Jan 2026
Net transactions value
-$33,392
Form type
4
Filing time
03 Feb 2026, 19:49:52 UTC
Previous filing
02 Feb 2026
Next filing
10 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hodges Michelle A Chief Legal Officer 9975 SUMMERS RIDGE ROAD, SAN DIEGO /s/ Phillip S. Askim, attorney-in-fact for Michelle A. Hodges 03 Feb 2026 0001833942

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QDEL Common Stock Award $0 +1,610 +4.3% $0.000000 38,970 31 Jan 2026 Direct F1
transaction QDEL Common Stock Tax liability $15,704 -578 -1.5% $27.17 38,392 31 Jan 2026 Direct F2
transaction QDEL Common Stock Award $0 +1,814 +4.7% $0.000000 40,206 31 Jan 2026 Direct F1
transaction QDEL Common Stock Tax liability $17,688 -651 -1.6% $27.17 39,555 31 Jan 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QDEL Restricted Stock Units Award $0 +38,562 $0.000000 38,562 30 Jan 2026 Common Stock 38,562 Direct F3, F4
transaction QDEL Non-Qualified Stock Options Award $0 +38,561 $0.000000 38,561 30 Jan 2026 Common Stock 38,561 $27.17 Direct F5
transaction QDEL Restricted Stock Units Options Exercise $0 -1,610 -100% $0.000000 0 31 Jan 2026 Common Stock 1,610 Direct F3, F6
transaction QDEL Restricted Stock Units Options Exercise $0 -1,814 -100% $0.000000 0 31 Jan 2026 Common Stock 1,814 Direct F3, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects release of restricted stock units that were previously reported on a Form 4.
F2 Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
F3 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F4 38,562 shares will vest in equal installments on January 30, 2027, January 30, 2028 and January 30, 2029.
F5 12,853 shares will vest on January 30, 2027; the remaining 25,708 shares will vest in equal installments on January 30, 2028 and January 30, 2029.
F6 1,610 shares vested on each of January 31, 2024, January 31, 2025 and January 31, 2026.
F7 3,628 shares vested on January 31, 2024; and 1,814 shares vested on each of January 31, 2025 and January 31, 2026.